arrow
S

Salvatore Russo

imperial college london
H指数:24
被引数:2,148

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Updating the Prevalence of H. pylori and Extensive Precancerous Lesions in the Stomach: Results of a Multicenter, Endoscopic Study

更新幽门螺杆菌感染及胃内广泛癌前病变的患病率:一项多中心内镜研究的结果

2026-09-190
OA
Intra-articular steroid injections for lumbar disk herniation: a systematic review and meta-analysis

椎间盘突出引起的腰痛的关节内类固醇注射:一项系统评价和荟萃分析

2025-11-140
PRE
Effectiveness and Safety of Orodispersible Budesonide for Eosinophilic Esophagitis: A Multicenter Real-World Study

奥洛地尔布地奈德治疗嗜酸性食管炎的有效性与安全性:一项多中心真实世界研究

2025-09-080
OAAI
The 1st EoETALY Consensus on the Diagnosis and Management of Eosinophilic Esophagitis-Current Treatment and Monitoring

关于嗜酸性食管炎的诊断和管理的第一个EoETALY共识-当前的治疗和监测

2024-07-0111
PRE
Pathologic complete response (pCR) to neoadjuvant treatment with or without atezolizumab in triple-negative, early high-risk and locally advanced breast cancer: NeoTRIP Michelangelo randomized study*

三阴性、早期高危和局部晚期乳腺癌患者接受或不接受阿特珠单抗新辅助治疗的病理完全缓解 (pCR): NeoTRIP Michelangelo随机研究 *

2022-05-01163
OAAI
A phase II single arm trial evaluating the efficacy and safety of eribulin in combination with bevacizumab for second-line treatment of human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer (MBC) progressing after first-line therapy with bevacizumab and paclitaxel
2019-02-150
PRE
PRELIMINARY DATA FROM A PROSPECTIVE NON-INTERVENTIONAL STUDY TO CHARACTERIZE REAL-WORLD TREATMENT PATTERNS AND OUTCOMES OF WOMEN WITH ER+/HER2-ADVANCED/METASTATIC BREAST CANCER
BREAST
IF7.9
2017-11-010
OAAI